Elevate your local knowledge
Sign up for the iNFOnews newsletter today!
NEW YORK, N.Y. – Stock futures were little changed on Tuesday, suggesting that a three-day slump in the market may abate. Investors will also start to focus on company earnings this week.
KEEPING SCORE: In pre-market trading, the Dow Jones industrial average futures slipped five points, which meant they were little changed at 16,173 as of 9:15 a.m. (1315 GMT). Standard & Poor’s 500 index futures were unchanged at 1,838. Nasdaq futures rose seven points, or 0.2 per cent, to 3,506.
THE SLUMP: The market logged its longest losing streak in two months Monday, extending a sell-off that began last week. A slump that started in technology and biotechnology stocks spread to companies that sell non-essential goods and services.
DRUG TROUBLE: Eli Lilly fell 63 cents, or 1.1 per cent, to $57.99 before the market opened. The stock declined after a U.S. jury ordered Japanese drugmaker Takeda Pharmaceutical Co. and its U.S. counterpart, Eli Lilly, to pay $9 billion in punitive damages over a diabetes medicine linked to cancer.
BONDS AND COMMODITIES: In government bond trading, the yield on the 10-year Treasury note edged up to 2.71 per cent from 2.70 per cent late Monday. The price of crude oil rose 78 cents to $101.22 a barrel. Gold rose $13.20, or 1 per cent, to $1,311.70 an ounce
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Want to share your thoughts, add context, or connect with others in your community?
You must be logged in to post a comment.